loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Lamivudine

    Menu

    Lamivudine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 106Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 205626 / DOSAGE - TABLET;ORAL - 150MG;200MG;300MG

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    LAMIVUDINE(UNII: 2T8Q726O95)
    (LAMIVUDINE - UNII:2T8Q726O95)     		LAMIVUDINE150mg
    NEVIRAPINE(UNII: 99DK7FVK1H)
    (NEVIRAPINE - UNII:99DK7FVK1H)     		NEVIRAPINE200mg
    ZIDOVUDINE(UNII: 4B9XT59T7S)
    (ZIDOVUDINE - UNII:4B9XT59T7S)     		ZIDOVUDINE300mg

    Inactive Ingredients

    Ingredient Name
    Micro Labs Limited
    CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
    HYPROMELLOSE 2910 (5 MPA.S)(R75537T0T4)
    LACTOSE MONOHYDRATE(EWQ57Q8I5X)
    MAGNESIUM STEARATE(70097M6I30)
    POLYETHYLENE GLYCOL 400(B697894SGQ)
    POLYSORBATE 80(6OZP39ZG8H)
    POVIDONE K25(K0KQV10C35)
    SILICON DIOXIDE(ETJ7Z6XBU4)
    SODIUM STARCH GLYCOLATE TYPE A POTATO(5856J3G2A2)
    TITANIUM DIOXIDE(15FIX9V2JP)